中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2015年
1期
10-11,12
,共3页
吴亮%董维%杨辉%林言华
吳亮%董維%楊輝%林言華
오량%동유%양휘%림언화
免疫疗法%再生障碍性贫血%相关因素
免疫療法%再生障礙性貧血%相關因素
면역요법%재생장애성빈혈%상관인소
Immune therapy%Aplastic anemia%Related factors
目的:探讨免疫疗法在再生障碍性贫血中的临床应用效果。方法:以2010年2月-2013年2月笔者所在医院收治的36例再生障碍性贫血患者为研究对象,均使用免疫抑制剂治疗,随访观察治疗效果,分析疗效影响因素。结果:36例患者经治疗后,总有效率达66.67%,治疗后血红蛋白、中性粒细胞、白细胞和血小板计数显著高于治疗前,差异有统计学意义(P<0.05),治疗过程中出现发热、血清病和皮疹等不良反应,远期并发症1例;单因素分析提示病程、严重感染与否同治疗效果存在显著相关性。结论:免疫疗法是再生障碍性贫血有效方案,病情确定后需及时实施,以提高治疗效果。
目的:探討免疫療法在再生障礙性貧血中的臨床應用效果。方法:以2010年2月-2013年2月筆者所在醫院收治的36例再生障礙性貧血患者為研究對象,均使用免疫抑製劑治療,隨訪觀察治療效果,分析療效影響因素。結果:36例患者經治療後,總有效率達66.67%,治療後血紅蛋白、中性粒細胞、白細胞和血小闆計數顯著高于治療前,差異有統計學意義(P<0.05),治療過程中齣現髮熱、血清病和皮疹等不良反應,遠期併髮癥1例;單因素分析提示病程、嚴重感染與否同治療效果存在顯著相關性。結論:免疫療法是再生障礙性貧血有效方案,病情確定後需及時實施,以提高治療效果。
목적:탐토면역요법재재생장애성빈혈중적림상응용효과。방법:이2010년2월-2013년2월필자소재의원수치적36례재생장애성빈혈환자위연구대상,균사용면역억제제치료,수방관찰치료효과,분석료효영향인소。결과:36례환자경치료후,총유효솔체66.67%,치료후혈홍단백、중성립세포、백세포화혈소판계수현저고우치료전,차이유통계학의의(P<0.05),치료과정중출현발열、혈청병화피진등불량반응,원기병발증1례;단인소분석제시병정、엄중감염여부동치료효과존재현저상관성。결론:면역요법시재생장애성빈혈유효방안,병정학정후수급시실시,이제고치료효과。
Objective:To investigate the clinical effect of immunetherapy in aplastic anemia.Method:From February 2010 to February 2013 in our hospital 36 aplastic anemia patients were chose as the research object,using of immunosuppressive therapy,the follow-up treatment effects were observed, efficacy analysis of influencing factors.Result:36 patients after treatment,the total effective rate was 66.67%,after treatment of neutrophil,hemoglobin,white blood cell and platelet count were significantly higher than that before treatment,the differences were statistically significant(P<0.05),fever,skin rash,serum sickness and no adverse reaction during the treatment,1 case of complications.Single factor analysis showed that the course of disease,severe infection and no significant correlation with therapeutic effect.Conclusion:Immune therapy is effective for regeneration barrier anemia,illness determine after the need for timely implementation,in order to improve the treatment effect.